perflexane has been researched along with Carcinoma, Ductal, Pancreatic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, S; Li, B; Li, X; Qin, J; Ren, J; Shuai, X; Wang, Y; Xiao, H; Zhong, Y | 1 |
1 other study(ies) available for perflexane and Carcinoma, Ductal, Pancreatic
| Article | Year |
|---|---|
Sono-promoted drug penetration and extracellular matrix modulation potentiate sonodynamic therapy of pancreatic ductal adenocarcinoma.
Topics: Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Extracellular Matrix; Humans; Pancreatic Neoplasms | 2023 |